The Role of BACH2 in T Cells in Experimental Malaria Caused by AS
Overview
Authors
Affiliations
BTB and CNC Homology 1, Basic Leucine Zipper Transcription Factor 2 (BACH2) is a transcription factor best known for its role in B cell development. More recently, it has been associated with T cell functions in inflammatory diseases, and has been proposed as a master transcriptional regulator within the T cell compartment. In this study, we employed T cell-specific -deficient (B6. ) mice to examine the role of this transcription factor in CD4 T cell functions and in mice infected with AS. We found that under CD4 T cell polarizing conditions , Th2, and Th17 helper cell subsets were more active in the absence of expression. In mice infected with AS, although the absence of expression by T cells had no effect on blood parasitemia or disease pathology, we found reduced expansion of CD4 T cells in B6. mice, compared with littermate controls. Despite this reduction, we observed increased frequencies of Tbet IFNγ CD4 (Th1) cells and IL-10-producing Th1 (Tr1) cells in mice lacking expression by T cells. Studies in mixed bone marrow chimeric mice revealed T cell intrinsic effects of BACH2 on hematopoietic cell development, and in particular, the generation of CD4 and CD8 T cell subsets. Furthermore, T cell intrinsic BACH2 was needed for efficient expansion of CD4 T cells during experimental malaria in this immunological setting. We also examined the response of B6. mice to a second protozoan parasitic challenge with and found similar effects on disease outcome and T cell responses. Together, our findings provide new insights into the role of BACH2 in CD4 T cell activation during experimental malaria, and highlight an important role for this transcription factor in the development and expansion of T cells under homeostatic conditions, as well as establishing the composition of the effector CD4 T cell compartment during infection.
An emerging maestro of immune regulation: how DOT1L orchestrates the harmonies of the immune system.
Kealy L, Runting J, Thiele D, Scheer S Front Immunol. 2024; 15:1385319.
PMID: 38962004 PMC: 11219580. DOI: 10.3389/fimmu.2024.1385319.
Poch T, Bahn J, Casar C, Krause J, Evangelakos I, Gilladi H Cell Rep Med. 2024; 5(7):101620.
PMID: 38901430 PMC: 11293351. DOI: 10.1016/j.xcrm.2024.101620.
Oliveira A, Aredes-Riguetti L, Pereira B, Alves C, Souza-Silva F Vaccines (Basel). 2023; 11(6).
PMID: 37376405 PMC: 10303393. DOI: 10.3390/vaccines11061015.